Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
62,315,169
-
Share change
-
+2,846,122
-
Total reported value
-
$1,814,633,448
-
Put/Call ratio
-
79%
-
Price per share
-
$29.12
-
Number of holders
-
115
-
Value change
-
+$85,319,986
-
Number of buys
-
66
-
Number of sells
-
34
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2022
As of 31 Dec 2022 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 62,315,169 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, NEA Management Company, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC.
This table shows 116 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.